Viking Therapeutics Ownership | Who Owns Viking Therapeutics?

Overview ForecastFinancials Chart Transcripts

Viking Therapeutics Ownership Summary

Viking Therapeutics is owned by 67.83% institutional investors, 2.15% insiders, and 30.03% retail investors. Fmr is the largest institutional shareholder, holding 15.07% of VKTX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 4.61% of its assets in Viking Therapeutics shares.

VKTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Viking Therapeutics	67.83%	2.15%	30.03%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	16.72M	15.07%	$672.63M
Vanguard group	10.17M	9.17%	$409.34M
Blackrock	6.03M	5.82%	$319.45M
State street	5.12M	4.95%	$271.54M
Blackrock funding, inc. /de	5.44M	4.85%	$144.09M
Jpmorgan chase	2.16M	1.95%	$86.82M
Pictet asset management sa	1.92M	1.71%	$50.80M
Geode capital management	1.88M	1.70%	$75.70M
Ameriprise financial	1.48M	1.33%	$59.54M
Braidwell lp	1.44M	1.28%	$38.10M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Profit investment management	116.85K	2.79%	$3.10M
5am venture management	189.59K	1.82%	$7.63M
Toms capital investment management lp	763.60K	1.52%	$40.48M
Braidwell lp	1.44M	1.30%	$38.10M
Artia global partners lp	90.28K	1.30%	$3.63M
Quantum private wealth	85.92K	1.11%	$3.46M
Apis capital advisors	116.51K	1.10%	$3.09M
First washington	59.12K	0.84%	$2.38M
Tejara capital	68.01K	0.84%	$1.80M
Maso capital partners	15.00K	0.70%	$397.50K

Top Buyers

Holder	Shares	% Assets	Change
State street	5.12M	0.01%	1.80M
Norges bank	1.28M	0.01%	1.28M
Ameriprise financial	1.48M	0.02%	1.03M
Balyasny asset management	860.45K	0.05%	860.45K
Toms capital investment management lp	763.60K	1.52%	763.60K

Top Sellers

Holder	Shares	% Assets	Change
Avoro capital advisors	-	-	-3.59M
Blackrock	6.03M	0.01%	-2.25M
Massachusetts financial services co /ma/	-	-	-1.36M
Perpetual	-	-	-1.27M
Westfield capital management co lp	-	-	-930.37K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.28M	0.01%	1.28M	$51.46M
Toms capital investment management lp	763.60K	1.52%	763.60K	$40.48M
Parallax volatility advisers	268.88K	0.02%	268.88K	$10.82M
Weiss asset management lp	121.78K	0.04%	121.78K	$3.23M
Alps advisors	60.63K	0.01%	60.63K	$1.61M

Sold Out

Holder	Change
True wealth design	-1.00
Concord wealth partners	-5.00
Capital advisors	-8.00
Scarborough advisors	-10.00
Main street group	-10.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	413	1.72%	76,058,977	0.09%	67	1.48%	224	-0.44%	108	3.85%
Mar 31, 2025	402	-10.67%	76,083,022	-7.14%	67	1.24%	220	-5.98%	105	-16.67%
Dec 31, 2024	414	-10.78%	75,828,361	-8.31%	68	1.23%	216	-21.17%	114	6.54%
Sep 30, 2024	460	6.48%	82,562,385	2.80%	74	1.41%	272	8.80%	106	-4.50%
Jun 30, 2024	428	0.71%	80,251,574	0.48%	77	1.08%	247	-12.72%	111	24.72%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	5.10M	4.61%	70.32K
Vanguard Total Stock Mkt Idx Inv	3.38M	3.00%	-72.21K
Vanguard US Total Market Shares ETF	3.32M	2.96%	2.50K
Vanguard Small Cap Index	2.59M	2.30%	-17.31K
SPDR® S&P Biotech ETF	1.91M	1.70%	47.13K
Strategic Advisers Fidelity US TtlStk	1.70M	1.51%	525.22K
Vanguard Small Cap Growth Index Inv	1.44M	1.28%	-556.00
Fidelity Select Health Care	1.34M	1.19%	340.00K
Vanguard Institutional Extnd Mkt Idx Tr	1.21M	1.07%	-529.99K
Fidelity Growth Compy Commingled Pl S	1.14M	1.01%	-454.62K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 03, 2025	Lian Brian	President & CEO	Sell	$747.63K
Jul 03, 2025	ZANTE GREG	Chief Financial Officer	Sell	$118.43K
Jul 03, 2025	Mancini Marianna	Chief Operating Officer	Sell	$118.47K
Mar 31, 2025	Rouan Sarah Kathryn	-	Buy	$29.94K
Jan 06, 2025	Lian Brian	President & CEO	Sell	$7.49M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	3
2025 Q2	-	-
2025 Q1	1	6
2024 Q4	-	11
2024 Q3	-	25

VKTX Ownership FAQ

Who Owns Viking Therapeutics?

Viking Therapeutics shareholders are primarily institutional investors at 67.83%, followed by 2.15% insiders and 30.02% retail investors. The average institutional ownership in Viking Therapeutics's industry, Biotech Stocks , is 306.59%, which Viking Therapeutics falls below.

Who owns the most shares of Viking Therapeutics?

Viking Therapeutics’s largest shareholders are Fmr (16.72M shares, 15.07%), Vanguard group (10.17M shares, 9.17%), and Blackrock (6.03M shares, 5.82%). Together, they hold 30.07% of Viking Therapeutics’s total shares outstanding.

Does Blackrock own Viking Therapeutics?

Yes, BlackRock owns 5.82% of Viking Therapeutics, totaling 6.03M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 319.45M$. In the last quarter, BlackRock decreased its holdings by -2.248M shares, a -27.17% change.

Who is Viking Therapeutics’s biggest shareholder by percentage of total assets invested?

Profit investment management is Viking Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.79% of its assets in 116.85K Viking Therapeutics shares, valued at 3.1M$.

Who is the top mutual fund holder of Viking Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Viking Therapeutics shares, with 4.61% of its total shares outstanding invested in 5.1M Viking Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools